Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
TL;DR: If you're looking for a powerful productivity suite without recurring subscription fees, Microsoft Office 2021 is available for just $35 for a limited time, an incredible deal. This offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback